Mission impossible accomplished? A European cross-national comparative study on the integration of the harm-benefit analysis into law and policy documents
PLOS ONE · 20.02.2024 · 19 (2) · e0297375
DOI: 10.1371/journal.pone.0297375 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.02.2024. Verfasst von Dominik Hajosi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Life Sciences, Messerli Research Institute, University of Veterinary Medicine Vienna, Medical University of Vienna, U…. Hauptthemen laut MEDLINE: Policy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The harm-benefit analysis (HBA) is a cornerstone of the European Directive 2010/63/EU (the Directive). The Directive regulates the care and handling of animals used for scientific purposes in the European Union (EU). Since its implementation, there has been ongoing debate around the practical applicability of the HBA for research project review processes. The objectives of this study are to analyze the operationalization of HBA in EU member states and investigate the consistency of HBA’s implementation in terms of national legislation and available policy documents. To meet these objectives, we evaluated the transposition of the HBA requirement into national legislation. We also conducted a comprehensive comparative cross-national analysis of all guidance documents pertinent to HBA. The results of our study show that there are (1) deficits in the transposition of the HBA requirement into national laws, (2) significant discrepancies in available policy documents relating to HBA, and (3) insufficiently consistent implementations of HBA in European countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Interdisciplinary Life Sciences, Messerli Research Institute, University of Veterinary Medicine Vienna, Medical University of Vienna, University of Vienna, Vienna, Austria.
- Institute of Comparative Medicine, Columbia University, New York, NY, United States of America.
ORCID-Profile: Dominik Hajosi
Zitieren
APA
Hajosi, D., & Grimm, H. (2024). Mission impossible accomplished? A European cross-national comparative study on the integration of the harm-benefit analysis into law and policy documents. PLOS ONE, 19(2), e0297375. https://doi.org/10.1371/journal.pone.0297375
Vancouver
Hajosi D, Grimm H. Mission impossible accomplished? A European cross-national comparative study on the integration of the harm-benefit analysis into law and policy documents. PLOS ONE. 2024;19(2):e0297375. doi:10.1371/journal.pone.0297375
BibTeX
@article{Hajosi2024,
author = {Hajosi, Dominik and Grimm, Herwig},
title = {Mission impossible accomplished? A European cross-national comparative study on the integration of the harm-benefit analysis into law and policy documents},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {2},
pages = {e0297375},
doi = {10.1371/journal.pone.0297375}
}
EUVIMED